Pneumonia

May 13, 2016May 13, 2016

Theravance Poster to Show Phase 3 ATTAIN Trial Results on Pneumonia at ATS 2016

News, Pneumonia

Theravance Biopharma, Inc. recently announced in a press release the presentation of new data on VIBATIV® (telavancin), the company’s FDA-approved antibiotic, at the American Thoracic Society (ATS) 2016 International Conference, May 13-18 in San Francisco. The ... Read more

May 12, 2016May 12, 2016

Hospital Stays for Children with Aspiration Pneumonia Longer, Pricier than Community-Acquired

News, Pneumonia

A recent study presented at the Pediatric Academic Societies Meeting, April 30-May 3 in Baltimore, Md., suggests that hospitalizations of children with aspiration pneumonia (AP) last longer and cost more ... Read more

May 5, 2016May 5, 2016

Rapid Diagnostic Test for Mycoplasma pneumoniae Receives EU Mark of Approval

News, Pneumonia

Meridian Bioscience, Inc., recently announced that its new molecular diagnostic test for Mycoplasma pneumoniae, illumigene Mycoplasma Direct assay, has received the CE mark, which establishes that the product meet the European Union’s safety, health ... Read more

May 5, 2016May 13, 2016

Cempra Asks FDA to Approve Antibiotic to Treat Community-Acquired Bacterial Pneumonia

News, Pneumonia

Cempra, Inc., announced that it has completed its rolling submission of a New Drug Application for solithromycin, a potential treatment for community-acquired bacterial pneumonia (CABP), to the U.S. Food and Drug Administration. The ... Read more

April 19, 2016April 19, 2016

Lung Ultrasound a Possible Alternative to Chest X-ray for Pneumonia Diagnosis in Kids

News, Pneumonia

A new research study demonstrated that lung ultrasound is a novel, efficient and safe option for the diagnosis of pneumonia, representing an alternative to chest X-ray in children. The study, ... Read more

April 6, 2016May 13, 2016

Pneumonia Epidemic on Rise in Beijing; Diagnoses Doubled in Children in 2015

News, Pneumonia

Investigators from the Capital Institute of Pediatrics in Beijing, China, identified an increase in infections caused by Mycoplasma pneumoniae almost a year ago. By December 2015, the pathogen had already been ... Read more

April 6, 2016April 6, 2016

Theravance to Present New Data on Antibiotic, Vibativ, for Bacterial Pneumonia at ECCMID 2016

News, Pneumonia

Theravance Biopharma, Inc., announced that data from a new study assessing Vibativ, an approved antibiotic, will be featured in a poster presentation at the 26th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). The ... Read more

March 14, 2016March 14, 2016

Greater Risk for COPD, Other Diseases Found with High Coronary Artery Calcium Scores, Study Shows

COPD, Lung Cancer, News, Pneumonia

People with a high coronary artery calcium (CAC) score puts them at increased risk not only for heart and vascular disease, but also for chronic obstructive pulmonary disease (COPD), cancer, and chronic ... Read more

March 11, 2016March 11, 2016

Vaccine Significantly Reduces Pneumococcal Disease in Gambian Children, UK Study Says

News, Pneumonia

A new study from a collaboration between the Gambian government, the Medical Research Council (MRC) of the United Kingdom, and partners such as the London School of Hygiene & Tropical ... Read more

February 18, 2016February 18, 2016

Oral Pneumonia Drug, Solithromycin, Shows Safety and Efficacy in Phase 3 Trial

News, Pneumonia

Cempra announced positive results from its Phase 3 multicenter trial of oral solithromycin versus oral moxifloxacin for community-acquired bacterial pneumonia. The clinical study, which appeared in the medical journal Lancet, found solithromycin to be of similar ... Read more